Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Jan;41(1):162–168. doi: 10.1128/aac.41.1.162

Effects of steroidal allenic phosphonic acid derivatives on the parasitic protists Leishmania donovani, Leishmania mexicana mexicana, and Pneumocystis carinii carinii.

D H Beach 1, F Chen 1, M T Cushion 1, R S Macomber 1, G A Krudy 1, M A Wyder 1, E S Kaneshiro 1
PMCID: PMC163678  PMID: 8980773

Abstract

Several pathogenic fungi and protozoa are known to have sterols distinct from those of their mammalian hosts. Of particular interest as targets for drug development are the biosyntheses of the sterols of important parasites such as the kinetoplastid flagellates and the AIDS-associated opportunistic protist Pneumocystis carinii. These pathogens synthesize sterols with an alkyl group at C-24, and some have a double bond at C-22 of the side chain. Humans and other mammalian hosts are incapable of C-24 alkylation and C-22 desaturation. In the present study, three steroidal compounds with side chains substituted by phosphonyl-linked groups were synthesized and tested for their effects on Leishmania donovani and L. mexicana mexicana culture growth. The compounds inhibited organism proliferation at concentrations in micrograms per milliliter. The most potent inhibitors of this group of compounds were characterized by two ethyl groups at the phosphate function. Leishmania organisms treated with 17-[2-(diethylphosphonato) ethylidienyl]3-methoxy-19-norpregna-1,3,5-triene exhibited reduced growth after transfer into inhibitor-free medium. Because there are currently no axenic methods available for the continuous subcultivation of P. carinii, the effects of these drugs on this organism were evaluated by two alternative screening methods. The same two diethyl phosphonosteroid compounds that inhibited Leishmania proliferation were also the most active against P. carinii as determined by the potent effect they had on reducing cellular ATP content. Cystic as well as trophic forms responded to the drug treatments, as evaluated by a dual fluorescent staining live-dead assay. Other modifications of steroidal phosphonates may lead to the development of related drugs with increased activity and specificity for the pathogens.

Full Text

The Full Text of this article is available as a PDF (194.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boylan C. J., Current W. L. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals. Infect Immun. 1992 Apr;60(4):1589–1597. doi: 10.1128/iai.60.4.1589-1597.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chen F., Cushion M. T. Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats. J Clin Microbiol. 1994 Nov;32(11):2791–2800. doi: 10.1128/jcm.32.11.2791-2800.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cushion M. T., Kaselis M., Stringer S. L., Stringer J. R. Genetic stability and diversity of Pneumocystis carinii infecting rat colonies. Infect Immun. 1993 Nov;61(11):4801–4813. doi: 10.1128/iai.61.11.4801-4813.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Florin-Christensen M., Florin-Christensen J., Wu Y. P., Zhou L., Gupta A., Rudney H., Kaneshiro E. S. Occurrence of specific sterols in Pneumocystis carinii. Biochem Biophys Res Commun. 1994 Jan 14;198(1):236–242. doi: 10.1006/bbrc.1994.1033. [DOI] [PubMed] [Google Scholar]
  5. Furlong S. T., Samia J. A., Rose R. M., Fishman J. A. Phytosterols are present in Pneumocystis carinii. Antimicrob Agents Chemother. 1994 Nov;38(11):2534–2540. doi: 10.1128/aac.38.11.2534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goad L. J., Holz G. G., Jr, Beach D. H. Effect of the allylamine antifungal drug SF 86-327 on the growth and sterol synthesis of Leishmania mexicana mexicana promastigotes. Biochem Pharmacol. 1985 Oct 15;34(20):3785–3788. doi: 10.1016/0006-2952(85)90250-3. [DOI] [PubMed] [Google Scholar]
  7. Kaneshiro E. S., Ellis J. E., Zhou L. H., Rudney H., Gupta A., Jayasimhulu K., Setchell K. D., Beach D. H. Isoprenoid metabolism in Pneumocystis carinii. J Eukaryot Microbiol. 1994 Sep-Oct;41(5):93S–93S. [PubMed] [Google Scholar]
  8. Kaneshiro E. S., Wyder M. A., Zhou L. H., Ellis J. E., Voelker D. R., Langreth S. G. Characterization of Pneumocystis carinii preparations developed for lipid analysis. J Eukaryot Microbiol. 1993 Nov-Dec;40(6):805–815. doi: 10.1111/j.1550-7408.1993.tb04479.x. [DOI] [PubMed] [Google Scholar]
  9. Lee C. H., Bauer N. L., Shaw M. M., Durkin M. M., Bartlett M. S., Queener S. F., Smith J. W. Proliferation of rat Pneumocystis carinii on cells sheeted on microcarrier beads in spinner flasks. J Clin Microbiol. 1993 Jun;31(6):1659–1662. doi: 10.1128/jcm.31.6.1659-1662.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mercer E. I. Sterol biosynthesis inhibitors: their current status and modes of action. Lipids. 1991 Aug;26(8):584–597. doi: 10.1007/BF02536422. [DOI] [PubMed] [Google Scholar]
  11. Nes W. D., Hanners P. K., Parish E. J. Control of fungal sterol C-24 transalkylation: importance to developmental regulation. Biochem Biophys Res Commun. 1986 Sep 14;139(2):410–415. doi: 10.1016/s0006-291x(86)80006-7. [DOI] [PubMed] [Google Scholar]
  12. Sleight R. G., Mehta M. A., Kaneshiro E. S. Uptake and metabolism of fluorescent lipid analogs by Pneumocystis carinii. J Eukaryot Microbiol. 1994 Sep-Oct;41(5):111S–111S. [PubMed] [Google Scholar]
  13. Steiger R. F., Steiger E. Cultivation of Leishmania donovani and Leishmania braziliensis in defined media: nutritional requirements. J Protozool. 1977 Aug;24(3):437–441. doi: 10.1111/j.1550-7408.1977.tb04771.x. [DOI] [PubMed] [Google Scholar]
  14. Tsai C. C., Follis K. E., Sabo A., Beck T. W., Grant R. F., Bischofberger N., Benveniste R. E., Black R. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science. 1995 Nov 17;270(5239):1197–1199. doi: 10.1126/science.270.5239.1197. [DOI] [PubMed] [Google Scholar]
  15. Yamada H., Tsuda T., Watanabe T., Ohashi M., Murakami K., Mochizuki H. In vitro and in vivo antifungal activities of D0870, a new triazole agent. Antimicrob Agents Chemother. 1993 Nov;37(11):2412–2417. doi: 10.1128/aac.37.11.2412. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES